Are you Dr. Steinkuller?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 30 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Suite 510.00
Houston, TX 77030Phone+1 832-822-3230Fax+1 832-825-4776
Summary
- Dr. Paul Steinkuller, MD is a board certified ophthalmologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is an Associate Professor at Baylor College of Medicine.
Education & Training
- MedStar Health/Georgetown-Washington Hospital CenterResidency, Ophthalmology, 1972 - 1975
- National Capital ConsortiumInternship, Transitional Year, 1967 - 1968
- George Washington University School of Medicine and Health SciencesClass of 1967
Certifications & Licensure
- TX State Medical License 1977 - 2022
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- 39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 244 citationsAn update on progress and the changing epidemiology of causes of childhood blindness worldwideLingkun Kong, Melinda Fry, Mohannad Al-Samarraie, Clare Gilbert, Paul G. Steinkuller
Journal of AAPOS. 2012-12-01 - 111 citationsPharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.Lingkun Kong, Amit R. Bhatt, Ann B. Demny, David K. Coats, Alexa L Li
Investigative Ophthalmology & Visual Science. 2015-01-22 - 3 citationsCortical Visual Impairment in Congenital Cytomegalovirus InfectionHaoxing Douglas Jin, Gail J. Demmler-Harrison, Jerry A. Miller, Jane C. Edmond, David K. Coats
Journal of Pediatric Ophthalmology and Strabismus. 2019-05-22
Press Mentions
- 2022 Year in Review: Building Community. Advancing InnovationDecember 31st, 2022
Professional Memberships
- Fellow